In this interview, Technology Networks spoke with Kara Egan, CEO and co-founder of Teal Health, to learn more about how they ...

While amyloid-beta has been a central focus in drug development, increasing evidence points to tau pathology as a more accurate predictor of disease progression. This is where the work of Dr. Naoto ...

We collect information you provide to us through our websites and to affiliated micro-sites that are owned and operated by Technology Networks Ltd. We collect your information when you subscribe to a ...